Porter Tracy A 4
Research Summary
AI-generated summary
Healthpeak (DOC) EVP Tracy A. Porter Receives LTIP Award
What Happened Tracy A. Porter, Executive Vice President and General Counsel of Healthpeak Properties, was granted two performance‑based LTIP awards on January 28, 2026 totaling 48,021 LTIP Units (11,256 and 36,765 units). These are awards (transaction code A) — not open‑market purchases or sales — and there was no per‑share cash price reported (N/A). The awards were determined to be earned by the Compensation and Human Capital Committee on the determination date and will vest over future anniversaries per the grant terms.
Key Details
- Transaction date: January 28, 2026 (Form filed Jan 30, 2026); transaction type: Award/Grant (A); price: N/A (no cash paid).
- Units granted: 11,256 LTIP Units and 36,765 LTIP Units, total 48,021 LTIP Units.
- Shares owned after transaction: Not specified in the provided filing.
- Footnote highlights:
- F1: LTIP Units are profits‑interest units in Healthpeak OP that have no expiration, are intended to qualify as profits interests for U.S. tax purposes, and are convertible (at holder election) into OP common units that are redeemable for cash equal to the fair market value of one share of Healthpeak common stock or, at OP’s option, convertible one‑for‑one into Healthpeak common shares.
- F2: 11,256 and/or 36,765 units represent performance‑based LTIP Units from prior grants (Feb 7 and May 1, 2025) that the Committee determined were earned on Jan 28, 2026; those units vest in one‑third increments on the first, second and third anniversaries of Feb 7, 2025, subject to continued employment.
- F3: Some units were from a March 3, 2025 grant whose performance condition was also satisfied on Jan 28, 2026; those units vest in one‑fifth increments on the 2nd–6th anniversaries of March 3, 2025, subject to continued employment.
- Timeliness: Filing appears timely (transaction 1/28/2026, Form 4 filed 1/30/2026).
Context These LTIP Units are derivative, performance‑based compensation awards that become economic or equity‑linked only as they vest and/or are converted into OP units or Healthpeak common shares. This is a grant/recognition of earned performance rather than a market purchase or sale and should be viewed as executive compensation, not a direct buy or sell signal.